Asthma / Inhalers

Asthalin

Asthalin

Asthalin is indicated for the relief of bronchospasm in asthma, chronic bronchitis and emphysema, and other conditions associated with airways obstruction. It is also indicated to prevent symptoms in circumstances recognised by the patient to precipitate an asthma attack (e.g. before exercise, unavoidable allergic exposure).

Asthalin Inhaler

Asthalin Inhaler

ASTHALIN is indicated in the treatment of bron­chospasm in bronchial asthma, chronic bronchitis and emphysema, and prophylaxis of exercise–induced asthma.

Asthalin Respules

Asthalin Respules

ASTHALIN Respules are indicated for use in the routine management of chronic bronchospasm unresponsive to conventional therapy, and in the treatment of acute severe asthma.

Beclate Inhaler

Beclate Inhaler

BECLATE Inhaler is indicated in the prophylactic management of mild, moderate, or severe asthma in adults or children.

 

Budecort Inhaler

Budecort Inhaler

BUDECORT Inhaler is indicated in patients with mild to severe persistent bronchial asthma.

BUDECORT Inhaler is not indicated for the relief of acute bronchospasm. 

Budecort respules

Budecort respules

BUDECORT respules is indicated for the maintenance treatment of asthma and as prophylactic therapy in children 12 months to 8 years of age. BUDECORT respules is not indicated for the relief of acute bronchospasm.

BUDECORT respules are also recommended for use in infants and children with acute laryngotracheobronchitis - croup.

Budecort Rotacaps

Budecort Rotacaps

BUDECORT Rotacaps is indicated for the maintenance treatment of asthma as prophylactic therapy in adult and pediatric patients six years of age or older. It is also indicated for patients requiring oral corticosteroid therapy for asthma. Many of those patients may be able to reduce or eliminate their requirement for oral corticosteroids over time.

BUDECORT Rotacaps are not indicated for the relief of acute bronchospasm.

  • 1
  • 2
  • 3